ADSCaN: a randomised phase II study of accelerated, dose escalated, sequential chemo-radiotherapy in non-small cell lung cancer (NSCLC)

Lawless, C.A. et al. (2017) ADSCaN: a randomised phase II study of accelerated, dose escalated, sequential chemo-radiotherapy in non-small cell lung cancer (NSCLC). UNSPECIFIED S80-S81. (doi:10.1016/S0169-5002(17)30221-0)

[img]
Preview
Text
159013.pdf - Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

713kB

Abstract

No abstract available.

Item Type:Conference or Workshop Item
Additional Information:Conference abstract from the 15th Annual British Thoracic Oncology Group Conference 2017, Dublin, Ireland, 25-27 Jan 2017.
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Paul, Mr James and McCartney, Miss Elaine and Boyd, Dr Kathleen
Authors: Lawless, C.A., Landau, D.A., Faivre-Finn, C., Boyd, K., Lester, J.F., Fenwick, J., Maguire, J., McCartney, E., Paul, J., Parsons, E., Peek, A., Haswell, T., and Hatton, M.Q.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cancer Sciences
College of Medical Veterinary and Life Sciences > Institute of Health and Wellbeing > Health Economics and Health Technology Assessment
Journal Name:Lung Cancer
Publisher:Elsevier
ISSN:0169-5002
ISSN (Online):1872-8332
Published Online:09 February 2017
Copyright Holders:Copyright © 2017 Elsevier Ireland Ltd.
First Published:First published in Lung Cancer 103: S80-S81
Publisher Policy:Reproduced in accordance with the publisher copyright policy

University Staff: Request a correction | Enlighten Editors: Update this record